Last quarter (Q4 2022), Calliditas Therapeutics's total revenue was kr―, a decrease of -100.00% from the same quarter last year. In Q4, Calliditas Therapeutics's net income was kr―. See Calliditas Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	kr 373.84M	kr 802.88M	kr 229.35M	kr 874.00K	kr 184.83M	kr 0.00
Cost of Revenue	kr 7.32M	kr -15.20M	-	-	-	-
Gross Profit	kr 366.52M	kr 787.68M	kr 229.35M	-	-	-
Operating Expense	kr 820.95M	kr 1.21B	kr 543.17M	kr 380.59M	kr 212.71M	kr 130.39M
Operating Income	kr -454.44M	kr -421.94M	kr -543.17M	kr -379.72M	kr -27.88M	kr -130.39M
Net Non Operating Interest Income Expense	kr 34.95M	kr 50.20M	kr 11.08M	kr -56.43M	kr 601.00K	kr -2.00K
Other Income Expense	-	kr 412.27M	kr 500.29M	kr -54.08M	kr -5.22M	kr -1.66M
Pretax Income	kr -419.48M	kr -409.42M	kr -1.03B	kr -436.15M	kr -32.50M	kr -132.05M
Tax Provision	kr -10.90M	kr 2.85M	kr -3.84M	kr 360.00K	kr 77.00K	kr 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -408.59M	kr -824.53M	kr -1.04B	kr -433.49M	kr -32.58M	kr -132.05M
Basic EPS	-	kr -7.78	kr -9.84	-	-	-
Diluted EPS	-	kr -7.78	kr -9.84	-	-	-
Basic Average Shares	-	kr 53.02M	kr 50.83M	-	-	-
Diluted Average Shares	-	kr 105.98M	kr 50.83M	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 828.27M	kr 1.19B	kr 543.17M	kr 380.59M	kr 212.71M	kr 130.39M
Net Income From Continuing And Discontinued Operation	kr -408.59M	kr -824.53M	kr -1.04B	kr -433.49M	kr -32.58M	kr -132.05M
Normalized Income	kr -408.59M	-	-	kr -433.49M	kr -28.47M	kr -130.39M
Interest Expense	-	-	-	kr 393.00K	kr 325.00K	kr 8.00K
EBIT	kr -454.44M	kr -440.61M	kr -1.02B	kr -379.72M	kr -32.18M	kr -132.04M
EBITDA	kr -454.44M	kr -453.52M	-	kr -379.72M	kr -30.35M	kr -131.99M

Currency in SEK

Calliditas Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing